Screener
PJP vs PBUS
Invesco Pharmaceuticals ETF vs Invesco MSCI USA ETF
Key differences
- PBUS costs 0.53% less per year.
- PBUS is significantly larger than PJP — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, PBUS has delivered higher annualized returns.
- PJP has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| PJP | PBUS | |
|---|---|---|
| Annual cost (TER) | 0.57% | 0.04% |
| Fund size (AUM) | $334M | $10.7B |
| Since | 2005 | 2017 |
| Dividend yield | 1.01% | 1.03% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +40.6% | +30.6% |
| CAGR 3Y | +14.0% | +23.2% |
| CAGR 5Y | +7.8% | +14.0% |
| Sharpe 3Y | 0.69 | 1.23 |
| Volatility 1Y | 16.23% | 12.22% |
| Max drawdown | -33.95% | -33.15% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to PJP and PBUS
Explore further